Sign in
4

Changes in Ownership

Roivant Sciences Ltd. Filed Acc 0001140361-23-049763

CEO disposed of 12,489 shares (other)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Gline Matthew CEO 2023-10-24 Other disposition 10b5-1 −12,489 $8.99 $112,276 1,028,751 D: show line 1 in the form
Loading xslF345X05/form4.xml…